Longitude Capital

Longitude Capital accounts for 33 tracked companies with verified cap-table data, 33 of which disclose round sizes totalling $7.5B. The median disclosed raise is $135M, and the largest is Vaxcyte at $2.4B, ahead of Somatus ($500M) and Nalu Medical ($396M).

The names that recur most often on these co-invested cap tables are Longitude Capital (33 companies), RA Capital Management (5 companies), Omega Funds (5 companies), Novo Holdings (4 companies), OrbiMed (4 companies), Decheng Capital (3 companies). By latest disclosed round, the market skews Series B (10), Series A (9), Series C (6), Series D (3).

• Companies tracked: 33
• Disclosed funding total: $7.5B across 33 companies
• Median disclosed raise: $135M
• Largest raise: Vaxcyte — $2.4B
• Stage mix: Series B 10 · Series A 9 · Series C 6 · Series D 3
• Most recent dated round: 2026-05-20

Best funded Longitude Capital companies

1. Vaxcyte — $2.4B (latest: IPO)
2. Somatus — $500M (latest: Series E)
3. Nalu Medical — $396M (latest: Growth)
4. Alentis Therapeutics — $366M (latest: Series D)
5. Talaris Therapeutics — $365M (latest: Other Equity)
6. Endeavor BioMedicines — $292M (latest: Series A)
7. CG Oncology — $200M (latest: IPO)
8. Kestra Medical Technologies, Inc. — $196M (latest: Series C)
9. Amunix — $193M (latest: Series B)
10. Ceribell — $188M (latest: Series C)
11. LEXEO Therapeutics — $185M (latest: Series B)
12. cAMPfield Therapeutics — $180M (latest: Series A)
13. Rivus Pharmaceuticals — $167M (latest: Series B)
14. Tricida — $153M (latest: Series D)
15. Quanta Therapeutics — $142M (latest: Series D)

Longitude Capital — related firms and companies (56)

• Vaxcyte
• Somatus
• Nalu Medical
• Alentis Therapeutics
• Talaris Therapeutics
• Endeavor BioMedicines
• CG Oncology
• Kestra Medical Technologies, Inc.
• Companies backed by Longitude Capital
• Rivus Pharmaceuticals
• Investors like Index Ventures
• Inozyme
• Investors like Goldman Sachs
• Epirium Bio
• Investors like Crossbeam Venture Partners
• 89bio
• Investors like Lightbank
• Investors like ACME Capital
• Tricida
• Investors like Irving Investors
• Alphaeon
• Investors like Founders Fund
• NOCD
• Investors like Upfront Ventures
• CuraSen Therapeutics
• Amunix
• Investors like Matrix
• Quanta Therapeutics
• Investors like ARCH Venture Partners
• Orbus Therapeutics
• Investors like boldstart ventures
• Sublimity Therapeutics
• Investors like Balderton Capital
• AvengeBio
• Ceribell
• Investors like Zetta Venture Partners
• Endogenex
• Investors like Gaingels
• Alpha9 Theranostics
• Investors like AME Cloud Ventures
• Zavante Therapeutics
• Investors like Acre Venture Partners
• Longitude Capital portfolio companies 2026
• LEXEO Therapeutics
• Investors like Peak XV Partners
• Aptinyx
• Investors like Expansion Venture Capital
• Checkmate Pharmaceuticals
• Investors like Google Ventures
• Helicore Biopharma
• Investors like IVP
• Investors like Longitude Capital
• cAMPfield Therapeutics
• Investors like DCVC
• OrsoBio
• Investors like Fika Ventures

Longitude Capital alternatives · All research reports